Greenwood Capital Associates LLC Grows Stock Position in InfuSystem Holdings, Inc. (NYSE:INFU)

Greenwood Capital Associates LLC boosted its stake in InfuSystem Holdings, Inc. (NYSE:INFU) by 14.0% in the third quarter, Holdings Channel reports. The fund owned 119,062 shares of the company’s stock after buying an additional 14,587 shares during the quarter. Greenwood Capital Associates LLC’s holdings in InfuSystem were worth $798,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Williams & Novak LLC purchased a new position in InfuSystem in the 3rd quarter worth approximately $70,000. Squarepoint Ops LLC purchased a new position in InfuSystem in the 2nd quarter worth approximately $230,000. Marshall Wace LLP purchased a new position in InfuSystem in the 2nd quarter worth approximately $131,000. First Eagle Investment Management LLC boosted its holdings in InfuSystem by 10.0% in the 2nd quarter. First Eagle Investment Management LLC now owns 666,048 shares of the company’s stock worth $4,549,000 after acquiring an additional 60,813 shares during the period. Finally, Oppenheimer Asset Management Inc. boosted its stake in shares of InfuSystem by 52.1% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 26,042 shares of the company’s stock valued at $178,000 after buying an additional 8,917 shares during the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.

Analyst Ratings Changes

INFU has been the subject of several research analyst reports. StockNews.com cut InfuSystem from a “strong-buy” rating to a “buy” rating in a research note on Saturday, September 28th. B. Riley initiated coverage on InfuSystem in a research note on Thursday, September 26th. They set a “buy” rating and a $13.00 target price for the company.

InfuSystem Stock Performance

INFU stock opened at $6.30 on Wednesday. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.07 and a quick ratio of 1.64. The company has a market capitalization of $134.32 million, a PE ratio of 630.63 and a beta of 1.45. InfuSystem Holdings, Inc. has a 1 year low of $5.74 and a 1 year high of $10.99. The company has a fifty day moving average of $6.54.

InfuSystem (NYSE:INFU) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). InfuSystem had a net margin of 0.28% and a return on equity of 0.70%. The company had revenue of $33.70 million for the quarter. As a group, analysts predict that InfuSystem Holdings, Inc. will post 0.17 EPS for the current fiscal year.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.